While no direct role has been uncovered for PE in insulin secretion, we have recently found that inhibition of the GPR40 receptor, a therapeutically relevant target for the treatment of diabetes [46], results in the accumulation of CDP-ethanolamine, concomitant with reduction in lipid cycling in β-cells [23]. The gene discussed is INS; the disease is diabetes mellitus.